RESEARCH-USE BIOSIMILAR ANTIBODY
Rovalpituzumab
Antibody-drug conjugate · IgG1
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC).
TARGETDLL3
YAntibody-drug conjugate
CATALOGSC-BS-201
CATALOG NUMBERSC-BS-201
MOLECULAR WEIGHTApprox. 145.02 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rovalpituzumab is a humanized monoclonal antibody against delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC).
Rovalpituzumab is a recombinant research-use antibody directed against DLL3.